Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             43 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A comprehensive patient assessment and physician reminder tool for adult immunization: Effect on vaccine administration Fishbein, Daniel B.
2006
24 18 p. 3971-3983
13 p.
artikel
2 Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis Oliveira-Freitas, E.
2006
24 18 p. 3909-3920
12 p.
artikel
3 A mutant of Escherichia coli enterotoxin inducing a specific Thl-type of T cells to varicella-zoster vaccine enhances the production of IL-12 by IFNγ-stimulated macrophages Shimizu, Toshiyasu
2006
24 18 p. 3719-3726
8 p.
artikel
4 A new intranasal influenza vaccine based on a novel polycationic lipid—ceramide carbamoyl-spermine (CCS) Joseph, Aviva
2006
24 18 p. 3990-4006
17 p.
artikel
5 An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits Wimer-Mackin, S.
2006
24 18 p. 3953-3963
11 p.
artikel
6 A randomised controlled study of the reactogenicity of an acellular pertussis-containing pentavalent infant vaccine compared to a quadrivalent whole cell pertussis-containing vaccine and oral poliomyelitis vaccine, when given concurrently with meningococcal group C conjugate vaccine to healthy UK infants at 2, 3 and 4 months of age Kitchin, Nicholas
2006
24 18 p. 3964-3970
7 p.
artikel
7 A short report on clinical evaluation of RIX4414: highlights of world-wide development Vos, B. De
2006
24 18 p. 3777-3778
2 p.
artikel
8 A short report on highlights of world-wide development of RIX4414: A Latin American experience Linhares, A.C.
2006
24 18 p. 3784-3785
2 p.
artikel
9 A short report on highlights of world-wide development of RIX4414: An European experience Vesikari, T.
2006
24 18 p. 3779-
1 p.
artikel
10 A short report on highlights of worldwide development of RIX4414: A Singaporean experience Phua, K.B.
2006
24 18 p. 3782-3783
2 p.
artikel
11 A short report on the highlights of world-wide development of RIX4414: a North American experience Dennehy, Penelope H.
2006
24 18 p. 3780-3781
2 p.
artikel
12 Biosafety evaluation of recombinant live oral bacterial vaccines in the context of European regulation Favre, Didier
2006
24 18 p. 3856-3864
9 p.
artikel
13 Catecholate receptor proteins in Salmonella enterica: role in virulence and implications for vaccine development Williams, P.H.
2006
24 18 p. 3840-3844
5 p.
artikel
14 Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers Carpenter, C.M.
2006
24 18 p. 3709-3718
10 p.
artikel
15 Construction and evaluation of a O139 Vibrio cholerae vaccine candidate based on a hemA gene mutation Ravichandran, Manickam
2006
24 18 p. 3750-3761
12 p.
artikel
16 Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli Zhu, Chengru
2006
24 18 p. 3821-3831
11 p.
artikel
17 DNA vaccines against enteric infections Herrmann, John E.
2006
24 18 p. 3705-3708
4 p.
artikel
18 DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses Borrego, Belen
2006
24 18 p. 3889-3899
11 p.
artikel
19 Editorial Board 2006
24 18 p. CO2-
1 p.
artikel
20 Enteric infections and the vaccines to counter them: Future directions Levine, Myron M.
2006
24 18 p. 3865-3873
9 p.
artikel
21 Establishment of a non-human primate Campylobacter disease model for the pre-clinical evaluation of Campylobacter vaccine formulations Islam, Dilara
2006
24 18 p. 3762-3771
10 p.
artikel
22 Human immune response towards recombinant Helicobacter pylori urease and cellular fractions Voland, Petra
2006
24 18 p. 3832-3839
8 p.
artikel
23 Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations Ramasamy, R.
2006
24 18 p. 3900-3908
9 p.
artikel
24 Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model Barry, Eileen M.
2006
24 18 p. 3727-3734
8 p.
artikel
25 Interchangeability of two diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate vaccines as a fourth dose in 15–20-month-old toddlers Halperin, Scott A.
2006
24 18 p. 4017-4023
7 p.
artikel
26 Intussusception and rotavirus vaccines Bines, Julie
2006
24 18 p. 3772-3776
5 p.
artikel
27 Late vaccination reinforcement during a measles epidemic in Niamey, Niger (2003–2004) Dubray, Christine
2006
24 18 p. 3984-3989
6 p.
artikel
28 Live, attenuated Salmonella typhimurium vectoring Campylobacter antigens Sizemore, Donata R.
2006
24 18 p. 3793-3803
11 p.
artikel
29 Local immune responses following nasal delivery of an adjuvanted influenza vaccine Scheerlinck, Jean-Pierre Y.
2006
24 18 p. 3929-3936
8 p.
artikel
30 Nonviral therapeutic cell vaccine mediates potent antitumor effects Moret-Tatay, Inés
2006
24 18 p. 3937-3945
9 p.
artikel
31 Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638 Talavera, A.
2006
24 18 p. 3746-3749
4 p.
artikel
32 Quantifying influenza vaccine efficacy and antigenic distance Gupta, Vishal
2006
24 18 p. 3881-3888
8 p.
artikel
33 Quantitative evaluation of genetic and environmental parameters determining antibody response induced by vaccination against bovine respiratory syncytial virus O’Neill, R.G.
2006
24 18 p. 4007-4016
10 p.
artikel
34 Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial McKenzie, R.
2006
24 18 p. 3735-3745
11 p.
artikel
35 Safety of influenza vaccinations administered in nontraditional settings D’Heilly, Sarah J.
2006
24 18 p. 4024-4027
4 p.
artikel
36 Survival of neutralizing antibody in previously rabies vaccinated subjects: A prospective study showing long lasting immunity Suwansrinon, K.
2006
24 18 p. 3878-3880
3 p.
artikel
37 The epidemiology of varicella and herpes zoster in The Netherlands: Implications for varicella zoster virus vaccination de Melker, Hester
2006
24 18 p. 3946-3952
7 p.
artikel
38 The jejunal Peyer's patches are the major inductive sites of the F4-specific immune response following intestinal immunisation of pigs with F4 (K88) fimbriae Snoeck, V.
2006
24 18 p. 3812-3820
9 p.
artikel
39 The MMR vaccination and autism controversy in United Kingdom 1998–2005: Inevitable community outrage or a failure of risk communication? Burgess, David C.
2006
24 18 p. 3921-3928
8 p.
artikel
40 The New World primate, Aotus nancymae, as a model for examining the immunogenicity of a prototype enterotoxigenic Escherichia coli subunit vaccine Jones, Franca R.
2006
24 18 p. 3786-3792
7 p.
artikel
41 Towards a vaccine for attaching/effacing Escherichia coli: a LEE encoded regulator (ler) mutant of rabbit enteropathogenic Escherichia coli is attenuated, immunogenic, and protects rabbits from lethal challenge with the wild-type virulent strain Zhu, Chengru
2006
24 18 p. 3845-3855
11 p.
artikel
42 Vaccines against typhoid fever Guzman, Carlos A.
2006
24 18 p. 3804-3811
8 p.
artikel
43 WHO discussion on the improvement of the quality control of BCG vaccines Knezevic, I.
2006
24 18 p. 3874-3877
4 p.
artikel
                             43 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland